CAS 210110-90-0
:3,4,5-Piperidinetriolo, 1-butil-2-(idrossimetil)-, cloridrato (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride, (2R,3R,4R,5S)-
- Miglustat HCl
- Miglustat hydrochloride
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
N-(n-Butyl)-1-deoxynojirimycin hydrochloride
CAS:N-(n-Butyl)-1-deoxynojirimycin hydrochlorideFormula:C10H21NO4·ClHPurezza:>99%Colore e forma:Solid-CrystalsPeso molecolare:255.73898(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFormula:C10H21NO4·ClHPurezza:98%Colore e forma:SolidPeso molecolare:255.73898Miglustat hydrochloride
CAS:Miglustat hydrochlorideFormula:C10H22ClNO4Purezza:99.5%Peso molecolare:255.742Miglustat HCl
CAS:Formula:C10H21NO4·HClColore e forma:White To Off-White SolidPeso molecolare:219.28 36.46Miglustat hydrochloride
CAS:Formula:C10H22ClNO4Purezza:98%Colore e forma:SolidPeso molecolare:255.7390N-Butyldeoxynojirimycin Hydrochloride
CAS:Prodotto controllatoApplications An inhibitor of a-glucosidase 1 as well as being an inhibitor of HIV cytopathicity. N-Butyldeoxynojirimycin has recently been used to retard lipid storage in the central nervous system of an animal model of Tay-Sachs disease.1-Deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.
References Hettkamp, H., et al.: Eur. J. Biochem., 142, 85 (1984), Szumilo, T., et al.: Arch. Biochem. Biophys., 247, 261 (1986), Fleet, G.W.J., et al.: FEBS Letters, 237, Number 1,2, 128 (1988), Kolter, T., et al.: Angew. Chem. Int. Ed. Engl., 36, 1955 (1997),Formula:C10H21NO4·ClHColore e forma:NeatPeso molecolare:255.74Miglustat HCl
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFormula:C10H22ClNO4Purezza:98%Peso molecolare:255.74N-Butyldeoxynojirimycin hydrochloride
CAS:Competitive inhibitor of ceramide-glycosyltransferase used for substrate reduction therapy in lysosomal storage disorders. It inhibits glucosylceramide synthase, which catalyses the initial step in glycosphingolipid biosynthetic pathway. This compound delays the onset of symptoms in type 1 Gaucher disease, Sandhoff disease and Tay-Sachs disease. It also reduces brain abnormalities in mucolipidosis type IV.
Formula:C10H21NO4•HClPurezza:Min. 95%Colore e forma:PowderPeso molecolare:255.74 g/molRef: ST-EA-CP-M20016
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaMiglustat hydrochloride
CAS:Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I GaucherFormula:C10H22ClNO4Purezza:99.85%Colore e forma:SolidPeso molecolare:255.74









